Products

Have an Emergency?

For urgent assistance, please contact emergency response services.

Call: 911

Product Questions?

Questions, comments or concerns about Rising Pharmaceuticals products? Contact one of our trusted professionals today.

Call (800) 521-5340
info@risingpharma.com

Compare Products

Compares to the labeled active ingredients in Reference Brand. The trademark or tradename referenced is NOT registered, owned or licensed by Rising Pharmaceuticals, Inc. or its affiliates.

A natural sourced antibiotic from Penicillin class, to treat ringworm infections.

Griseofulvin Microsize Tablets, USP

Griseofulvin Microsize Tablets, USP

Compare to: Grifulvin V® Tablets*
Strength: 500mg
* Grifulvin® is a registered trademark of Valeant International SRL.
This information has been designed as a quick reference. It is intended as a reference source only and not for prescribing or dispensing product. The appropriate approved prescribing information should be consulted. Images viewed herein may appear different than they do when viewing them live because of computer and/or photographic distortion. In addition, over time, some images and information for a particular product may change. For the most up-to-date product information, please contact your pharmacist or physician.

Griseofulvin is indicated for the treatment of dermatophyte infections of the skin not adequately treated by topical therapy, hair and nails, namely:

Tinea corporis

Tinea pedis

Tinea cruris

Tinea barbae

Tinea capitis

Tinea unguium when caused by one or more of the following species of fungi:

Epidermophyton floccosum

Microsporum audouinii

Microsporum canis

Microsporum gypseum

Trichophyton crateriform

Trichophyton gallinae

Trichophyton interdigitalis

Trichophyton megnini

Trichophyton mentagrophytes

Trichophyton rubrum

Trichophyton schoenleini

Trichophyton sulphureum

Trichophyton tonsurans

Trichophyton verrucosum

Note: Prior to therapy, a dermatophyte should be identified as responsible for the infection.

Prior to initiating treatment, appropriate specimens for laboratory testing (KOH preparation, fungal culture, or nail biopsy) should be obtained to confirm the diagnosis.

Griseofulvin is not effective in the following:

Bacterial infections

Candidiasis (Moniliasis)

Histoplasmosis

Actinomycosis

Sporotrichosis

Chromoblastomycosis

Coccidioidomycosis

North American Blastomycosis

Cryptococcosis (Torulosis)

Tinea versicolor

Nocardiosis


The use of this drug is not justified in minor or trivial dermatophyte infections which will respond to topical agents alone.